|
131 |
The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study
Enthalten in Breast cancer research and treatment Bd. 111, 21.9.2007, Nr. 1, date:9.2008: 139-144
|
|
|
|
132 |
The impact of breast cancer awareness and socioeconomic status on willingness to receive breast cancer prevention drugs
Enthalten in Breast cancer research and treatment Bd. 101, 11.10.2006, Nr. 1, date:1.2007: 95-104
|
|
|
|
133 |
The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study
Enthalten in Breast cancer research Bd. 14, 7.12.2012, Nr. 6, date:12.2012: 1-8
|
|
|
|
134 |
Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study
Enthalten in BMC cancer Bd. 6, 17.11.2006, Nr. 1, date:12.2006: 1-4
|
|
|
|
135 |
Umstrukturierung der Risikoberechnung für die intensivierte Früherkennung im Deutschen Konsortium für Brust- und Eierstockkrebs
Enthalten in Der Gynäkologe Bd. 53, 28.2.2020, Nr. 4, date:4.2020: 259-264
|
|
|
|
136 |
Use of biologically-based complementary medicine in breast and gynecological cancer patients during systemic therapy
Enthalten in BMC complementary and alternative medicine Bd. 18, 24.9.2018, Nr. 1, date:12.2018: 1-7
|
|
|
|
137 |
Validation of the German version of the Mediterranean Diet Adherence Screener (MEDAS) questionnaire
Enthalten in BMC cancer Bd. 17, 18.5.2017, Nr. 1, date:12.2017: 1-10
|
|
Administration
